A Blood Test to Prognosticate Progression-Free and Overall Survival in Cancer Patients
The benefits of this invention include high sensitivity (very low false negatives); minimally invasive as only blood samples are required; high specificity (no false positives); can be part of a broader panel of markers; can be utilized as a marker for all solid tumors, given the biology and fundamental role in metastasis.
Detection of these markers bears prognostic significance; and testing blood of patients could be done before, during and after chemotherapy in order to monitor patient response.
This invention teaches a method of evaluating cancer progression and dissemination by monitoring a specific biomarker alone or in combination with other biomarkers. The inventor has determined that detection of specific tumor cell biomarkers is a valuable method of determining cancer progression in patients.
Intellectual Property Info A patent application has been filed. Tech ID/UC Case 23335/2013-244-0 Related Cases 2013-244-0
美国
